New Immunotherapy Cancer Treatment Opdivo (Nivolumab)

FDA approved immountherapy Opdivo (nivolumab) is a promising cancer drug treatment for different types of cancers, including melanoma, kidney cancer, lung cancer and Hodgkin lymphoma. In this video, oncologist Stephen Lemon MD talks about how this treatment helps to activate the patient’s immune system to fight back against the cancer.

Opdivo is developed by Bristol-Myers Squibb, Dr. Lemon with the Lighter Side of Cancer produces these videos to help provide more useful cancer information to patients and survivors. Dr. Lemon is not affiliated with Bristol-Myers Squibb.

Click on the buttons below to view more videos that we have produced

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email